¡Ya estamos en ! Descubre más
LHDX

Lucira Health, Inc. Common Stock

Excluida de cotización

LHDX dejó de cotizar en bolsa el 3 de marzo de 2023.

 

Acerca de: Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. It has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fit in the palm of a hand. The company's initial focus is within respiratory diseases, and initially for COVID-19 and influenza Types A and B indications.

Empleados: 221

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%

No hemos recibido artículos de noticias recientes sobre LHDX.

Gráficos de precios implementados con Lightweight Charts™